Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 9:14:1171131.
doi: 10.3389/fgene.2023.1171131. eCollection 2023.

The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind", Santorini, Greece, 23-26 May 2022

Sophie Visvikis-Siest  1 , Maria G Stathopoulou  2 , Raute Sunder-Plassmann  3 , Behrooz Z Alizadeh  4 , Robert Barouki  5 , Ekaterina Chatzaki  6   7 , Georges Dagher  8   9   10   11 , George Dedoussis  12 , Panagiotis Deloukas  13 , Alexander Haliassos  14 , Brigitte Boisson Hiegel  1 , Vangelis Manolopoulos  6   15 , Christine Masson  1 , Guillaume Paré  16 , Markus Paulmichl  17 , Alexandros M Petrelis  1   18 , Csilla Sipeky  19 , Belgin Süsleyici  20 , Georges Weryha  1 , Alex Chenchik  21 , Paul Diehl  21 , Robin E Everts  22 , Alexander Haushofer  23 , John Lamont  24 , Ruth Mercado  21 , Heiko Meyer  25 , Herna Munoz-Galeano  26 , Helena Murray  24 , Ferrier Nhat  27 , Charity Nofziger  28 , Wolfgang Schnitzel  28 , Stavroula Kanoni  13
Affiliations
Editorial

The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind", Santorini, Greece, 23-26 May 2022

Sophie Visvikis-Siest et al. Front Genet. .
No abstract available

Keywords: cancer; genetic screening; heart inflammation; medical diagnostic; personalized medicine; pharmacogenomics; systems medicine; “-OMICs” biomarkers.

PubMed Disclaimer

Conflict of interest statement

Author AP was employed by the company Digitsole. Author CS was employed by the company UCB Pharma, Author AC, PD, RM were employed by the company Cellecta, Authors RE was employed by the company Agena (United States), Author AH was employed by the company Randox, Authors HM was employed by the company Agena (Germany), Author FN was employed by the company Thermo Fisher Scientific, Author CN, WS were employed by the company PharmGenetix. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic The 10th Santorini conference: Systems medicine, personalised health and therapy. “The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini, Greece, 23–26 May 2022

References

    1. Alix-Panabieres C., Cayrefourcq L., Mazard T., Maudelonde T., Assenat E., Assou S. (2017). Molecular portrait of metastasis-competent circulating tumor cells in colon cancer reveals the crucial role of genes regulating energy metabolism and DNA repair. Clin. Chem. 63(3), 700–713. 10.1373/clinchem.2016.263582 - DOI - PubMed
    1. Alix-Panabieres C., Pantel K. (2014). Challenges in circulating tumour cell research. Nat. Rev. Cancer 14(9), 623–631. 10.1038/nrc3820 - DOI - PubMed
    1. Alix-Panabieres C., Pantel K. (2021). Liquid biopsy: From discovery to clinical application. Cancer Discov. 11 (4), 858–873. 10.1158/2159-8290.CD-20-1311 - DOI - PubMed
    1. Alix-Panabieres C. (2020). The future of liquid biopsy. Nature 579 (7800), S9. 10.1038/d41586-020-00844-5) - DOI - PubMed
    1. Amerikanou C., Kanoni S., Kaliora A. C., Barone A., Bjelan M., D'Auria G., et al. (2021). Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH randomised, controlled trial. Mol. Nutr. Food Res. 65 (10), e2001178. 10.1002/mnfr.202001178 - DOI - PubMed

Publication types

LinkOut - more resources